These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17164128)

  • 1. Cyclic AMP-dependent modulation of cardiac L-type Ca2+ and transient outward K+ channel activities by epoxyeicosatrienoic acids.
    Xiao YF
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):11-8. PubMed ID: 17164128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of cardiac L-type Ca2+ currents in transgenic mice with cardiac-specific overexpression of CYP2J2.
    Xiao YF; Ke Q; Seubert JM; Bradbury JA; Graves J; Degraff LM; Falck JR; Krausz K; Gelboin HV; Morgan JP; Zeldin DC
    Mol Pharmacol; 2004 Dec; 66(6):1607-16. PubMed ID: 15361551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac and vascular KATP channels in rats are activated by endogenous epoxyeicosatrienoic acids through different mechanisms.
    Lu T; Ye D; Wang X; Seubert JM; Graves JP; Bradbury JA; Zeldin DC; Lee HC
    J Physiol; 2006 Sep; 575(Pt 2):627-44. PubMed ID: 16793897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the Ca2 permeable cation channel TRPV4 by cytochrome P450 epoxygenases in vascular endothelium.
    Vriens J; Owsianik G; Fisslthaler B; Suzuki M; Janssens A; Voets T; Morisseau C; Hammock BD; Fleming I; Busse R; Nilius B
    Circ Res; 2005 Oct; 97(9):908-15. PubMed ID: 16179585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and p42/p44 MAPK pathway.
    Seubert J; Yang B; Bradbury JA; Graves J; Degraff LM; Gabel S; Gooch R; Foley J; Newman J; Mao L; Rockman HA; Hammock BD; Murphy E; Zeldin DC
    Circ Res; 2004 Sep; 95(5):506-14. PubMed ID: 15256482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epoxyeicosatrienoic acid prevents postischemic electrocardiogram abnormalities in an isolated heart model.
    Batchu SN; Law E; Brocks DR; Falck JR; Seubert JM
    J Mol Cell Cardiol; 2009 Jan; 46(1):67-74. PubMed ID: 18973759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450 and arachidonic acid metabolites: role in myocardial ischemia/reperfusion injury revisited.
    Gross GJ; Falck JR; Gross ER; Isbell M; Moore J; Nithipatikom K
    Cardiovasc Res; 2005 Oct; 68(1):18-25. PubMed ID: 15993870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epoxyeicosatrienoic acids regulate Trp channel dependent Ca2+ signaling and hyperpolarization in endothelial cells.
    Fleming I; Rueben A; Popp R; Fisslthaler B; Schrodt S; Sander A; Haendeler J; Falck JR; Morisseau C; Hammock BD; Busse R
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2612-8. PubMed ID: 17872452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome P450: a novel system modulating Ca2+ channels and contraction in mammalian heart cells.
    Xiao YF; Huang L; Morgan JP
    J Physiol; 1998 May; 508 ( Pt 3)(Pt 3):777-92. PubMed ID: 9518732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of cytochrome P450 metabolites of arachidonic acid in coronary venous plasma during ischemia and reperfusion in dogs.
    Nithipatikom K; DiCamelli RF; Kohler S; Gumina RJ; Falck JR; Campbell WB; Gross GJ
    Anal Biochem; 2001 May; 292(1):115-24. PubMed ID: 11319825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epoxyeicosatrienoic acids limit damage to mitochondrial function following stress in cardiac cells.
    Katragadda D; Batchu SN; Cho WJ; Chaudhary KR; Falck JR; Seubert JM
    J Mol Cell Cardiol; 2009 Jun; 46(6):867-75. PubMed ID: 19285984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of cytochrome P450-dependent transient receptor potential V4 activation in flow-induced vasodilatation.
    Loot AE; Popp R; Fisslthaler B; Vriens J; Nilius B; Fleming I
    Cardiovasc Res; 2008 Dec; 80(3):445-52. PubMed ID: 18682435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epoxyeicosatrienoic acids function as selective, endogenous antagonists of native thromboxane receptors: identification of a novel mechanism of vasodilation.
    Behm DJ; Ogbonna A; Wu C; Burns-Kurtis CL; Douglas SA
    J Pharmacol Exp Ther; 2009 Jan; 328(1):231-9. PubMed ID: 18836067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of ATP-sensitive K(+) channels by epoxyeicosatrienoic acids in rat cardiac ventricular myocytes.
    Lu T; Hoshi T; Weintraub NL; Spector AA; Lee HC
    J Physiol; 2001 Dec; 537(Pt 3):811-27. PubMed ID: 11744757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epoxyeicosatrienoic acids, cell signaling and angiogenesis.
    Fleming I
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):60-7. PubMed ID: 17164133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of epoxyeicosatrienoic acids on volume-activated chloride channels in rat mesenteric arterial smooth muscle.
    Yang C; Kwan YW; Seto SW; Leung GP
    Prostaglandins Other Lipid Mediat; 2008 Dec; 87(1-4):62-7. PubMed ID: 18812234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of epoxyeicosatrienoic acids in protecting the myocardium following ischemia/reperfusion injury.
    Seubert JM; Zeldin DC; Nithipatikom K; Gross GJ
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):50-9. PubMed ID: 17164132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of cardiac L-type calcium channels by epoxyeicosatrienoic acids.
    Chen J; Capdevila JH; Zeldin DC; Rosenberg RL
    Mol Pharmacol; 1999 Feb; 55(2):288-95. PubMed ID: 9927620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases.
    Xu X; Zhang XA; Wang DW
    Adv Drug Deliv Rev; 2011 Jul; 63(8):597-609. PubMed ID: 21477627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of epoxyeicosatrienoic acids in vascular regulation and cardiac preconditioning.
    Gauthier KM; Yang W; Gross GJ; Campbell WB
    J Cardiovasc Pharmacol; 2007 Dec; 50(6):601-8. PubMed ID: 18091575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.